[1]Yusibov V, Streatfield SJ, Kushnir N. Clinical development of plant-produced recombinant pharmaceuticals:vaccines, antibodies and beyond[J]. Hum Vaccin, 2011, 7(3):313-321. [2]Hefferon K. Plant-derived pharmaceuticals for the developing world[J]. Biotechnol J, 2013, 8(10):1193-1202. [3]Mason H S, Herbst-Kralovetz MM. Plant-derived antigens as mucosal vaccines[J]. Curr Top Microbiol Immunol, 2012, 354:101-120. [4]Hamza T, Barnett JB, Li B. Interleukin 12 a key immunoregulatory cytokine in infection applications[J]. Int J Mol Sci, 2010, 11(3):789-806. [5]Croxford AL, Kulig P, Becher B. IL-12-and IL-23 in health and disease[J]. Cytokine Growth Factor Rev, 2014, 25(4):415-421. [6]Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity[J]. Nat Rev Immunol, 2003, 3(2):133-146. [7]Sabalza M, Christou P, Capell T. Recombinant plant-derived pharmaceutical proteins:current technical and economic bottlenecks[J]. Biotechnol Lett, 2014, 36(12):2367-2379. [8]Twyman RM, Schillberg S, Fischer R. Optimizing the yield of recombinant pharmaceutical proteins in plants[J]. Curr Pharm Des, 2013, 19(31):5486-5494. [9]Park Y, Cheong H. Expression and production of recombinant human interleukin-2 in potato plants[J]. Protein Expr Purif, 2002, 25(1):160-165. [10]杨加伟, 李伟, 葛正龙. 马铃薯块茎特异性启动子克隆及其驱动的hIL12表达载体构建[J]. 遵义医学院学报, 2014, 37(4):38-43. [11]宋艳茹, 李枞, 侯林林, 等. 双价外壳蛋白基因植物表达载体的构建及马铃薯转基因植株的鉴定[J]. 植物学报, 1994, 36(11):842-848. [12]杨加伟, 程小玲, 葛正龙. 马铃薯叶片特异性启动子克隆分析及其驱动的人白细胞介素-12表达载体构建[J]. 基因组学与应用生物学, 2014, 33(4):875-881. [13]胡显文, 陈惠鹏, 张树庸. 全球生物制药产业概况[J]. 中国医药生物技术, 2009, 4(2):85-89. [14]Assenberg R, Wan PT, Geisse S, et al. Advances in recombinant protein expression for use in pharmaceutical research[J]. Curr Opin Struct Biol, 2013, 23(3):393-402. [15]Nausch H, Huckauf J, Koslowski R, et al. Recombinant production of human interleukin 6 in Escherichia coli[J]. PLoS One, 2013, 8(1):e54933. [16]Luo Y, Kong X, Xu A, et al. Expression, purification, and functional characterization of recombinant human interleukin-7[J]. Protein Expr Purif, 2009, 63(1):1-4. [17]Esfandiar S, Hashemi-Najafabadi S, Shojaosadati SA, et al. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2[J]. Biotechnol Appl Biochem, 2012, 55(4):209-214. [18]Lico C, Santi L, Twyman RM, et al. The use of plants for the production of therapeutic human peptides[J]. Plant Cell Rep, 2012, 31(3):439-451. [19] Magnuson NS, Linzmaier PM, Reeves R, et al. Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture[J]. Protein Expr Purif, 1998, 13(1):45-52. [20]Liu J, Dolan MC, Reidy M, et al. Expression of bioactive single-chain murine IL-12 in transgenic plants[J]. J Interferon Cytokine Res, 2008, 28(6):381-392. [21]Bortesi L, Rossato M, Schuster F, et al. Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco[J]. BMC Biotechnol, 2009, 9:22. [22]宋东光, 张辉松, 聂呈荣, 等. 口蹄疫病毒VP1基因转化马铃薯及其块茎专一性表达[J]. 生物技术通报, 2011(2):107-109, 173. [23]宋东光, 邓日烈, 聂呈荣, 等. ELISA检测人降钙素基因相关肽在转基因马铃薯块茎中的专一性表达[J]. 生物技术通报, 2010(7):117-119. [24]Ma S, Huang Y, Davis A, et al. Production of biologically active human interleukin-4 in transgenic tobacco and potato[J]. Plant Biotechnol J, 2005, 3:309-318. [25] Gutie'rrez-Ortega A, A'vila-Moreno F, Saucedo-Arias LJ, et al. Expression of a single-chain human Interleukin-12 gene in transgenic tobacco plants and functional studies[J]. Biotechnology and Bioengineering, 2004, 85(7):734-740. [26]陈佳瑜, 刘喜平, 葛正龙. 转基因马铃薯中人白介素212的生物学活性[J]. 第三军医大学学报, 2010, 32(15):1632-1634. [27]陈佳瑜, 罗果, 葛正龙. 人白介素IL-12转基因马铃薯中hIL-12的表达[J]. 安徽农业科学, 2010, 38(15):7767-7768. [28]Stupar RM, Beaubien KA, Jin W, et al. Structural diversity and differential transcription of the patatin multicopy gene family during potato tuber development[J]. Genetics, 2006, 172(2):1263-1275.
|